Research Article
Elevated Serum IGFBP-2 and CTGF Levels Are Associated with Disease Activity in Patients with Dermatomyositis
Table 1
Characteristics of patients with DM.
| | Characteristics | HC () | DM () |
| | Age (years, ) | 47.73 ± 7.64 | 47.71 ± 10.88 | | Gender (F/M) | 26/4 | 48/17 | | ILD (Y/N) | | 33/32 | | ANA (+) | | 35 (53.85) | | Anti-MDA-5 (+) | | 27 (41.54) | | Anti-Ro-52 (+) | | 22 (33.85) | | Treatments for DM | | | | Glucocorticoids | | 64 (98.46) | | More than two immunosuppressors | | 59 (90.77) | | Treatments for ILD | | | | Pirfenidone | | 12 (36.4) | | Fluimucil | | 18 (54.5) | | CRP (mg/L, median and quartile) | | 3.11 (1.43, 5.77) | | CK (IU/L, median and quartile) | | 60 (39, 133) | | LDH (IU/L, median and quartile) | | 247 (215, 343) | | HBDH (IU/L, median and quartile) | | 194 (173, 285) |
|
|
